Evidence map›Paper›PMID 23100419›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.

Magali H Arons, Charlotte J Thynne, Andreas M Grabrucker, Dong Li, Michael Schoen, Juliette E Cheyne, Tobias M Boeckers, Johanna M Montgomery, Craig C Garner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 3 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 3 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Altered Structural Plasticity Mediated by mGlu and NMDA Receptors and Impaired Cognition in a Genetic ASD Model (Shank3The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Case Report: Co-occurringFrontiers in genetics · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Differential effectiveness of dietary zinc supplementation with autism-related behaviours inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Magali H AronsDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California 94304, USA.
Charlotte J Thynne
Andreas M Grabrucker
Dong Li
Michael Schoen
Juliette E Cheyne
Tobias M Boeckers
Johanna M Montgomery
Craig C Garner
University of Auckland · NZInstitute of Cell Biology and Neurobiology · ITStanford Medicine · USStanford University · US

Funding

The Roles of Presynaptic Plasticity in Circuit Function and BehaviorP01NS053862 · NINDS · STANFORD UNIVERSITY · PI GARNER, CRAIG C · 2006 to 2010
$6.7M
Identification of Autism genes that regulate synaptic Nrx/Nlg signaling complexesR21MH091471 · NIMH · STANFORD UNIVERSITY · PI GARNER, CRAIG C · 2010 to 2011
$431k
Regulation of activity-dependent ProSAp2 synaptic dynamicsF31NS066786 · NINDS · STANFORD UNIVERSITY · PI ROWAN, MAGALI HOLT · 2009 to 2011
$116k
NIMH NIH HHS R21 MH091471NINDS NIH HHS 5F31NS066786-025NINDS NIH HHS P01 NS053862
6 · The paper itself

Abstract

Mutations in several postsynaptic proteins have recently been implicated in the molecular pathogenesis of autism and autism spectrum disorders (ASDs), including Neuroligins, Neurexins, and members of the ProSAP/Shank family, thereby suggesting that these genetic forms of autism may share common synaptic mechanisms. Initial studies of ASD-associated mutations in ProSAP2/Shank3 support a role for this protein in glutamate receptor function and spine morphology, but these synaptic phenotypes are not universally penetrant, indicating that other core facets of ProSAP2/Shank3 function must underlie synaptic deficits in patients with ASDs. In the present study, we have examined whether the ability of ProSAP2/Shank3 to interact with the cytoplasmic tail of Neuroligins functions to coordinate pre/postsynaptic signaling through the Neurexin-Neuroligin signaling complex in hippocampal neurons of Rattus norvegicus. Indeed, we find that synaptic levels of ProSAP2/Shank3 regulate AMPA and NMDA receptor-mediated synaptic transmission and induce widespread changes in the levels of presynaptic and postsynaptic proteins via Neurexin-Neuroligin transsynaptic signaling. ASD-associated mutations in ProSAP2/Shank3 disrupt not only postsynaptic AMPA and NMDA receptor signaling but also interfere with the ability of ProSAP2/Shank3 to signal across the synapse to alter presynaptic structure and function. These data indicate that ASD-associated mutations in a subset of synaptic proteins may target core cellular pathways that coordinate the functional matching and maturation of excitatory synapses in the CNS.

Indexed as

6-Cyano-7-nitroquinoxaline-2,3-dioneAnalysis of VarianceAnimalsCadherinsCarrier ProteinsCell Adhesion Molecules, NeuronalCells, CulturedDizocilpine MaleateEmbryo, MammalianExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsFemaleGreen Fluorescent ProteinsHippocampusHumansMale6-Cyano-7-nitroquinoxaline-2,3-dioneCadherinsCarrier ProteinsCell Adhesion Molecules, NeuronalDizocilpine Maleateenhanced green fluorescent proteinExcitatory Amino Acid AntagonistsFM 4-64Green Fluorescent ProteinsNerve Tissue ProteinsPyridinium CompoundsQuaternary Ammonium CompoundsRNA, Small InterferingSHANK3 protein, humanVesicular Glutamate Transport Protein 1

Identifiers

PMID23100419
PMCPMC3752148
OpenAlexW2099220311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.